↓ Skip to main content

Inequalities in Health Impact of Alternative Reimbursement Pathways for Nirsevimab in the United States

Overview of attention for article published in Journal of Infectious Diseases, August 2022
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (51st percentile)

Mentioned by

twitter
2 X users
video
1 YouTube creator

Readers on

mendeley
26 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Inequalities in Health Impact of Alternative Reimbursement Pathways for Nirsevimab in the United States
Published in
Journal of Infectious Diseases, August 2022
DOI 10.1093/infdis/jiac164
Pubmed ID
Authors

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 26 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Geographical breakdown
Country Count As %
Unknown 26 100%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Student > Bachelor 3 12%
Student > Master 2 8%
Researcher 2 8%
Student > Postgraduate 2 8%
Librarian 1 4%
Other 1 4%
Unknown 15 58%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 4 15%
Nursing and Health Professions 3 12%
Economics, Econometrics and Finance 2 8%
Pharmacology, Toxicology and Pharmaceutical Science 1 4%
Psychology 1 4%
Other 1 4%
Unknown 14 54%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 June 2023.
All research outputs
#22,067,566
of 34,400,738 outputs
Outputs from Journal of Infectious Diseases
#16,066
of 18,989 outputs
Outputs of similar age
#216,931
of 453,448 outputs
Outputs of similar age from Journal of Infectious Diseases
#86
of 108 outputs
Altmetric has tracked 34,400,738 research outputs across all sources so far. This one is in the 35th percentile – i.e., 35% of other outputs scored the same or lower than it.
So far Altmetric has tracked 18,989 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 17.0. This one is in the 14th percentile – i.e., 14% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 453,448 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 51% of its contemporaries.
We're also able to compare this research output to 108 others from the same source and published within six weeks on either side of this one. This one is in the 20th percentile – i.e., 20% of its contemporaries scored the same or lower than it.